To this end, we have aimed our work to the analysis of the KCASH2 proximal promoter for the identification of key transcriptional regulators of this gene, which may be modulated by drugs, either positively or negatively, allowing the activation of this new “physiologic” repressor of the Hh pathway in tumor cells. The gene discussed is KCTD21; the disease is neoplasm.